Icahn School of Medicine at Mount Sinai: Cognitive Dysfunction trials

The registry lists 24 Cognitive Dysfunction studies with Icahn School of Medicine at Mount Sinai as lead sponsor. 3 are open to participants now and 6 have results posted.

Phase 2 1Phase 3 1Phase 4 4No phase 18(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Fareon Open Label Device Clinical TrialNot yet recruitingNCT07600320Not applicable
• Memory Support System for Older Chinese Americans With Mild Cognitive ImpairmentRecruitingNCT07142499Not applicable
• Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease PatientsRecruitingNCT05016219Not applicable
• Mitigation of Postoperative Delirium in High-Risk PatientsTerminatedNCT05777187Not applicableResults posted
• Understanding Circadian Responses to Light in Persons With Mild Cognitive ImpairmentCompletedNCT05411822Not applicableResults posted
• Rhythmic Light Therapy for Alzheimer's Disease PatientsCompletedNCT05015478Not applicableResults posted
• Trajectory of Recovery in the ElderlyCompletedNCT02275026Not applicableResults posted
• Perioperative Cognitive Function - Dexmedetomidine and Cognitive ReserveCompletedNCT00561678Phase 4Results posted
• Cognitive Protection - Dexmedetomidine and Cognitive ReserveTerminatedNCT00455143Phase 4Results posted
• The Use of Rhythmic Light Therapy in Mild Cognitive ImpairmentCompletedNCT07318038Not applicable
• Humanity Neurotech Device Clinical Trial in Adults With Long COVID Cognitive DysfunctionCompletedNCT06739668Not applicable
• Investigating the Impact of Duration and Amount of Light on the Circadian System Response - Aim 3CompletedNCT06595030Not applicable
• A Light Exposure Tracker Designed to Improve Circadian Rhythms - Aim 1CompletedNCT06356337Not applicable
• Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive ImpairmentActive, not recruitingNCT06069843Phase 2
• 7T MRI for Light Therapy in Patients With Mild Cognitive Impairment and Mild ADCompletedNCT05596994Not applicable
• Cognitive Rehabilitation for Post-COVID-19 Cognitive ImpairmentCompletedNCT05498493Not applicable
• Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)CompletedNCT04666077Not applicable
• The Long-term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive ImpairmentCompletedNCT04073628Not applicable
• Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2CompletedNCT03933696Not applicable
• Optimizing Postoperative Cognition the ElderlyCompletedNCT02650687
• Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With ModafinilCompletedNCT01965925Phase 4
• Treating Cancer-Related Fatigue Through Systematic Light ExposureCompletedNCT01873794Not applicable
• Role of Absolute Cerebral Oximetry to Prevent Neurocognitive Injury in Elderly Patients Undergoing Cardiac SurgeryTerminatedNCT00991328Phase 3
• Elder Surgery - Functional Recovery Following Beta BlockadeCompletedNCT00507663Phase 4